172 related articles for article (PubMed ID: 9538187)
1. NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.
Heys SD; Langlois N; Smith IC; Walker LG; Eremin O
Oncol Rep; 1998; 5(3):735-9. PubMed ID: 9538187
[TBL] [Abstract][Full Text] [Related]
2. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
3. [nm23 gene product/NDPK expression and its clinical significance in human colorectal carcinoma].
Wang C; Zhang X; Yang F
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):356-8. PubMed ID: 8732091
[TBL] [Abstract][Full Text] [Related]
4. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
5. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.
Zeng ZS; Hsu S; Zhang ZF; Cohen AM; Enker WE; Turnbull AA; Guillem JG
Br J Cancer; 1994 Nov; 70(5):1025-30. PubMed ID: 7947079
[TBL] [Abstract][Full Text] [Related]
6. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
7. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
Fan YZ; Li XP; Liu WF; Li GM
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
10. Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.
Belev B; Alerić I; Vrbanec D; Petrovecki M; Unusic J; Jakić-Razumović J
Acta Oncol; 2002; 41(4):355-61. PubMed ID: 12234027
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Eur J Cardiothorac Surg; 2001 Jun; 19(6):904-7. PubMed ID: 11404150
[TBL] [Abstract][Full Text] [Related]
13. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
14. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms.
Ohshio G; Imamura T; Okada N; Suwa H; Yamaki K; Imamura M; Ogasahara K; Tsukayama C; Yamabe H
Int J Pancreatol; 1997 Aug; 22(1):59-66. PubMed ID: 9387026
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of the role of NM23-H1 in colorectal cancers.
Lee JC; Lin YJ; Chow NH; Wang ST
J Surg Oncol; 2001 Jan; 76(1):58-62. PubMed ID: 11223826
[TBL] [Abstract][Full Text] [Related]
17. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
19. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.
Oliveira LA; Artigiani-Neto R; Waisberg DR; Fernandes LC; Lima Fde O; Waisberg J
Arq Gastroenterol; 2010; 47(4):361-7. PubMed ID: 21225146
[TBL] [Abstract][Full Text] [Related]
20. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
